President Trump published letters to 17 major pharma companies reiterating his requirements for them to fulfill his MFN order ...

Approval is based on results from the Phase III VALIANT trial (NCT05067127), in which Empaveli demonstrated a 68% reduction ...

Viridian Therapeutics partners with Kissei Pharmaceutical to advance treatments for thyroid eye disease in Japan, enhancing patient care and market potential.

Aetna enhances user experience with AI-driven Care Paths, simplifying health navigation and personalizing care for members ...

The exciting part part of AI application in clinical development is the use of the digital patient profile, which can lead to ...

The results showed that people started mirroring the eating habits of GLP-1 users even when they weren’t taking the ...